e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Interferon-gamma releases assays (IGRAs) for the diagnosis of tuberculosis: what is the role?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical evaluation of two interferon-gamma release assay tests for immunocompromised patients
Y. Kobashi, M. Abe, K. Mouri, Y. Obase, N. Miyashita, M. Oka (Kurashiki, Japan)
Source:
Annual Congress 2010 - Interferon-gamma releases assays (IGRAs) for the diagnosis of tuberculosis: what is the role?
Session:
Interferon-gamma releases assays (IGRAs) for the diagnosis of tuberculosis: what is the role?
Session type:
Oral Presentation
Number:
2150
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Kobashi, M. Abe, K. Mouri, Y. Obase, N. Miyashita, M. Oka (Kurashiki, Japan). Clinical evaluation of two interferon-gamma release assay tests for immunocompromised patients. Eur Respir J 2010; 36: Suppl. 54, 2150
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Clinical evaluation of interferon-gamma release assay (IGRA) in patients with nontuberculous mycobacterial disease
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
The role of interferon-gamma release assays for the diagnosis of tuberculosis
Source: Annual Congress 2011 - TBNET: tuberculosis research in Europe
Year: 2011
Concordance between tuberculin skin testing and interferon-gamma release assays in diagnosis of latent tuberculosis infection among HIV-infected individuals
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
Utility of a T-cell interferon-gamma release assay for the diagnosis of tuberculous serositis: A prospective study in Beijing, China
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
Use of tuberculin skin test, IFN-gamma release assays and IFN-gamma-induced protein-10 to identify children with TB infection
Source: Eur Respir J 2013; 41: 644-648
Year: 2013
Comparison of whole-blood interferon-gamma release assay and tuberculin skin test results for the prediction of active tuberculosis disease in HIV-infected individuals
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
Serial interferon-gamma release assay in children with tuberculosis infection
Source: Annual Congress 2010 - Tuberculosis in children
Year: 2010
Comparative study of the usefulness of TST and three interferon-gamma release assasys (IGRAs) for the differential diagnosis of pulmonary tuberculosis
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Update: T-cell interferon-gamma release assays for the diagnosis of MTB infection
Source: Annual Congress 2008 - PG20 - Advances in the diagnosis of Mycobacterium tuberculosis infection: an interactive, case-based course
Year: 2008
Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis
Source: Eur Respir J 2008; 32: 1607-1615
Year: 2008
Use of interferon-gamma release assays in diagnosis of active TB infection - Experience of a rural UK hospital
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Use of an ELISPOT interferon-gamma release assay for screening of end-stage renal failure contacts in haemodialysis centres
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Diagnosis of tuberculosis: principles and practice of using Interferon-gamma release assays (IGRAs)
Source: Breathe 2009; 5: 302-309
Year: 2009
Diagnostic performance of the interferon gamma release assay in elderly patients and clinical factors to support the diagnosis of active tuberculosis
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
Performance of two interferon-gamma release assays (T-SPOT.TB and QuantiFERON-TB GOLD In Tube) increase diagnostic yield of tuberculin skin testing for detection of latent tuberculosis in patients with inflammatory bowel disease
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011
Concordance between tuberculin skin test and interferon-gamma release assay in
Mycobacterium tuberculosis
infected children aged up to five years
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010
Support of ex vivo IFN-gamma release assays in the diagnosis of tuberculosis infection in HIV/AIDS patients
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Discordance between tuberculin skin tests (TST) and interferon gamma release assays (IGRAs): Are we over-treating LTBI?
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Clinical utility of pleural fluid interferon-gamma release assay in tuberculous pleurisy diagnosis
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept